The AUCs of the cisterna chyli diameter, age, albumin, sodium, blood urea nitrogen (BUN), BUN/creatinine, c-reactive protein, model for end-stage liver disease score, fractional excretion of sodium, and urinary sodium for evaluating the effect of tolvaptan were 0.911, 0.539, 0.597, 0.551, 0.656, 0.631, 0.547, 0.587, 0.627, and 0.5, respectively. The gene discussed is CRP; the disease is End Stage Liver Disease.